{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17622645",
  "DateCompleted": {
    "Year": "2008",
    "Month": "03",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2008",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2007",
        "Month": "07",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1525-8882",
      "JournalIssue": {
        "Volume": "2007",
        "Issue": "394",
        "PubDate": {
          "Year": "2007",
          "Month": "Jul",
          "Day": "10"
        }
      },
      "Title": "Science's STKE : signal transduction knowledge environment",
      "ISOAbbreviation": "Sci STKE"
    },
    "ArticleTitle": "Ceramide: from embryos to tumors.",
    "Pagination": {
      "StartPage": "jc1",
      "MedlinePgn": "jc1"
    },
    "Abstract": {
      "AbstractText": [
        "Ceramides are ubiquitous lipids that have important functions integral to apoptotic signaling. Several therapeutic agents currently exist that induce ceramide-dependent apoptosis in cancerous cells, and a number of enzymes involved in ceramide metabolism are beginning to be recognized as potential targets for cancer therapy. Recent research shows that evasion of ceramide-dependent apoptosis is essential at the earliest stages of embryonic development and is an important mechanism of multidrug resistance. Although ceramide-based strategies for treating cancer are promising, current data about ceramide-resistant tumors require further understanding of the role of ceramide in apoptosis."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biology, Pennsylvania State University, University Park, PA 16802, USA. ixs138@psu.edu"
          }
        ],
        "LastName": "Savtchouk",
        "ForeName": "Iaroslav A",
        "Initials": "IA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mattie",
        "ForeName": "Floyd J",
        "Initials": "FJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ollis",
        "ForeName": "Anne A",
        "Initials": "AA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Sci STKE",
    "NlmUniqueID": "100964423",
    "ISSNLinking": "1525-8882"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Ceramides"
    },
    {
      "RegistryNumber": "EC 3.2.1.47",
      "NameOfSubstance": "Galactosylgalactosylglucosylceramidase"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Apoptosis"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Ceramides"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Drug Resistance, Multiple"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Galactosylgalactosylglucosylceramidase"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Gene Expression Regulation, Neoplastic"
    },
    {
      "QualifierName": [
        "metabolism",
        "prevention & control"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Signal Transduction"
    }
  ],
  "NumberOfReferences": "18"
}